Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.45 USD | +0.48% | -4.58% | -42.29% |
04-25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
04-25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.29% | 746M | |
+2.91% | 108B | |
+10.26% | 105B | |
+1.57% | 23.46B | |
-12.22% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.74% | 17.19B | |
+6.38% | 13.99B | |
+36.81% | 12.53B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- JPMorgan Raises Price Target on Sage Therapeutics to $29 From $24, Maintains Overweight Rating